Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Trethera Awarded $3 Million NIH Grant to Advance First-In-Class Drug, TRE-515, for the Treatment of Lupus
Posted On Tuesday, August 19, 2025
Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways
Posted On Tuesday, August 19, 2025
Kyowa Kirin Premiers New CTCL Staging Tool for Healthcare Providers
Posted On Tuesday, August 19, 2025
60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Posted On Tuesday, August 19, 2025
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
Posted On Tuesday, August 19, 2025
BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
Posted On Tuesday, August 19, 2025
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
Posted On Tuesday, August 19, 2025
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
Posted On Tuesday, August 19, 2025
Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC
Posted On Tuesday, August 19, 2025
COUR Pharma Doses First Patient in Clinical Trial Evaluating CNP-103 in People Recently Diagnosed with Type 1 Diabetes
Posted On Tuesday, August 19, 2025
SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
Posted On Tuesday, August 19, 2025
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
Posted On Tuesday, August 19, 2025
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
Posted On Tuesday, August 19, 2025
ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors
Posted On Tuesday, August 19, 2025
Milestone® Pharmaceuticals to Present at Upcoming Conferences
Posted On Tuesday, August 19, 2025
Angitia Biopharmaceuticals to Present Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025
Posted On Tuesday, August 19, 2025
Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
Posted On Tuesday, August 19, 2025
BioXcel Therapeutics Announces Database Lock in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
Posted On Tuesday, August 19, 2025
Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform
Posted On Tuesday, August 19, 2025
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
Posted On Tuesday, August 19, 2025
Scientists Discuss the Recent CancerVax Breakthrough
Posted On Tuesday, August 19, 2025
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
Posted On Monday, August 18, 2025
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
Posted On Monday, August 18, 2025
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Monday, August 18, 2025
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
Posted On Monday, August 18, 2025

Print